Goldman Sachs’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
JGC
SPM
ACM
LK
XT
Goldman Sachs's PYPD Position: Q4 2025 in Review
Goldman Sachs sold out of PolyPid (PYPD) in Q4 2025, closing a stake of 14,292 shares — an estimated $47.7K sold.
Goldman Sachs first reported a position in PYPD in Q3 2025 and held it in 1 quarter. The position peaked at $47.7K in Q3 2025. 19 funds tracked by Wall St. Rank hold PYPD as of Q4 2025.
- Goldman Sachs reported no remaining PolyPid position as of Q4 2025 after selling out during the quarter.
- Goldman Sachs sold 14,292 PolyPid shares in Q4 2025, an estimated $47.7K.
- Goldman Sachs first reported a position in PolyPid in Q3 2025 and held it in 1 quarter.
- Goldman Sachs's PolyPid position peaked at $47.7K in Q3 2025.
- 19 funds tracked by Wall St. Rank held PolyPid as of Q4 2025.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.